Deutsche Bank’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.83M | Buy |
211,637
+188,675
| +822% | +$2.52M | ﹤0.01% | 1503 |
|
|
2025
Q1 | $234K | Sell |
22,962
-3,995
| -15% | -$40.7K | ﹤0.01% | 2859 |
|
|
2024
Q4 | $427K | Buy |
26,957
+8,447
| +46% | +$134K | ﹤0.01% | 2661 |
|
|
2024
Q3 | $1.07M | Sell |
18,510
-105,603
| -85% | -$6.13M | ﹤0.01% | 2039 |
|
|
2024
Q2 | $5.67M | Buy |
124,113
+41
| +0% | +$1.87K | ﹤0.01% | 1191 |
|
|
2024
Q1 | $8.21M | Sell |
124,072
-234,204
| -65% | -$15.5M | ﹤0.01% | 1083 |
|
|
2023
Q4 | $14.2M | Buy |
358,276
+345,704
| +2,750% | +$13.7M | 0.01% | 884 |
|
|
2023
Q3 | $401K | Sell |
12,572
-70,319
| -85% | -$2.24M | ﹤0.01% | 2286 |
|
|
2023
Q2 | $3.33M | Sell |
82,891
-4,505
| -5% | -$181K | ﹤0.01% | 1399 |
|
|
2023
Q1 | $3.73M | Buy |
87,396
+75,946
| +663% | +$3.24M | ﹤0.01% | 1357 |
|
|
2022
Q4 | $550K | Buy |
11,450
+3,406
| +42% | +$164K | ﹤0.01% | 2392 |
|
|
2022
Q3 | $303K | Sell |
8,044
-2,231
| -22% | -$84K | ﹤0.01% | 2671 |
|
|
2022
Q2 | $285K | Buy |
10,275
+135
| +1% | +$3.75K | ﹤0.01% | 2935 |
|
|
2022
Q1 | $552K | Sell |
10,140
-1,006
| -9% | -$54.8K | ﹤0.01% | 2674 |
|
|
2021
Q4 | $652K | Buy |
11,146
+369
| +3% | +$21.6K | ﹤0.01% | 2659 |
|
|
2021
Q3 | $427K | Sell |
10,777
-287
| -3% | -$11.4K | ﹤0.01% | 3134 |
|
|
2021
Q2 | $469K | Buy |
11,064
+1,412
| +15% | +$59.9K | ﹤0.01% | 3247 |
|
|
2021
Q1 | $593K | Sell |
9,652
-792
| -8% | -$48.7K | ﹤0.01% | 2982 |
|
|
2020
Q4 | $736K | Buy |
10,444
+6,592
| +171% | +$465K | ﹤0.01% | 2639 |
|
|
2020
Q3 | $149K | Buy |
3,852
+336
| +10% | +$13K | ﹤0.01% | 3325 |
|
|
2020
Q2 | $132K | Buy |
+3,516
| New | +$132K | ﹤0.01% | 3276 |
|